Most people have heard of yellow fever because of international travel requirements, yet relatively few understand what the disease actually is or why it continues to concern public health experts today.
Yellow fever is a serious viral infection that has affected human populations for centuries. Although outbreaks are now less common than they once were, the disease remains endemic in several parts of Africa and South America and continues to cause severe illness and preventable deaths each year.
As a GP, I've found that many patients assume yellow fever is simply another tropical illness that causes a few days of fever before improving. In reality, while many people experience only mild symptoms, others can develop life-threatening complications affecting the liver, kidneys, heart and brain. One of the challenges is that the illness often begins like many other viral infections, making early recognition difficult without considering a person's recent travel history.
The good news is that yellow fever is largely preventable, and understanding how the disease develops can help travellers, healthcare professionals and the wider public recognise when medical assessment is needed.
This guide explains the science behind yellow fever, how it affects the body, the symptoms to watch for, how doctors diagnose and treat the disease, and the practical steps that can reduce the risk of infection.
Yellow fever is an acute viral haemorrhagic fever, meaning it is a viral infection that can damage blood vessels and, in severe cases, cause abnormal bleeding. The disease takes its name from the yellowing of the skin and eyes—known as jaundice—that develops when the liver becomes significantly affected.
The virus naturally circulates between mosquitoes and non-human primates in tropical environments. Humans become infected when they are bitten by an infected mosquito, particularly while living in or travelling through regions where the virus is endemic.
One important point is that not everyone who contracts yellow fever becomes seriously ill. Some people experience only a mild flu-like illness, while others may have no noticeable symptoms at all. However, because it's impossible to predict who will develop severe disease, yellow fever remains a significant global health concern.
Many patients assume the disease is named after the colour of the mosquito or the virus itself. In fact, the term yellow fever refers to jaundice, a condition where the skin and the whites of the eyes turn yellow.
This happens because the virus can damage liver cells, reducing the liver's ability to process bilirubin—a yellow pigment produced when red blood cells are broken down. As bilirubin builds up in the bloodstream, it causes the characteristic yellow discoloration associated with advanced disease.
It's important to note that not everyone with yellow fever develops jaundice. It is typically seen in more severe cases and should be regarded as a warning sign that urgent medical care is required.
Yellow fever has shaped global public health for hundreds of years.
Major outbreaks have been recorded since the 17th century, affecting cities across the Americas, Africa and parts of Europe through international trade and maritime travel. Before scientists understood how mosquitoes transmitted the virus, entire communities experienced devastating epidemics.
One of the most significant breakthroughs came in the early 1900s, when researchers confirmed that mosquitoes—not contaminated air or direct human contact—were responsible for spreading the disease. This discovery transformed public health strategies and paved the way for mosquito control programmes that remain an essential part of prevention today.
Although modern medicine has reduced the impact of yellow fever, outbreaks still occur, particularly in areas where vaccination coverage is low or mosquito populations are difficult to control.
Yellow fever is caused by the yellow fever virus (YFV), an RNA virus belonging to the Flaviviridae family. Other viruses in this group include dengue virus, Zika virus and West Nile virus, all of which are spread by mosquitoes.
Unlike bacteria, viruses cannot reproduce on their own. Instead, the yellow fever virus invades healthy human cells and uses them to create thousands of new viral particles. These newly formed viruses then spread through the bloodstream, allowing the infection to affect different organs.
Understanding how the virus behaves inside the body helps explain why some people develop only mild symptoms while others experience widespread organ damage.
The infection begins with the bite of an infected mosquito.
At first, the virus multiplies near the site of the bite before entering the lymphatic system and bloodstream. From there, it travels to organs where it can continue replicating, particularly the liver.
Over the next few days, the immune system recognises the virus and begins producing antibodies in an attempt to control the infection. In many individuals, this immune response is sufficient to clear the virus.
However, if the virus continues to multiply unchecked, inflammation can spread throughout the body, leading to damage of vital organs and blood vessels.
This widespread organ involvement explains why severe yellow fever can become a medical emergency requiring intensive hospital care.
Once the immune system detects the virus, it releases specialised white blood cells and antibodies to fight the infection.
For many people, this response successfully controls the virus before significant organ damage occurs. These individuals often recover completely and develop long-term immunity.
In others, however, an excessive inflammatory response can contribute to tissue damage. This combination of viral replication and immune-mediated inflammation is one reason why severe yellow fever can progress rapidly.
Unlike illnesses such as influenza or COVID-19, yellow fever does not spread directly from person to person. You cannot catch it by coughing, sneezing, shaking hands, sharing food or being in the same room as someone who is infected.
Instead, transmission depends on infected mosquitoes acting as vectors. A mosquito becomes infected after feeding on the blood of an infected human or non-human primate. The virus then multiplies inside the mosquito before being passed to another person during a subsequent bite.
This mosquito-dependent transmission is one reason why yellow fever remains confined to particular parts of the world. Without the right mosquito species and environmental conditions, the virus cannot establish ongoing transmission.
Although the process is biologically complex, it can be understood in five simple stages.
Unlike diseases spread through contaminated food or water, yellow fever relies entirely on this mosquito-human transmission cycle.
Several mosquito species can carry the yellow fever virus, but the most important is Aedes aegypti.
These mosquitoes are particularly efficient because they:
This behaviour increases opportunities for the virus to spread within communities during outbreaks.
Many people assume yellow fever is a disease of the past. While vaccination programmes have significantly reduced its impact, outbreaks continue to occur for several reasons.
Communities with limited access to vaccination remain vulnerable to outbreaks.
Rapid urbanisation creates dense populations where mosquitoes can spread infection more efficiently.
Warmer temperatures and changing rainfall patterns influence mosquito breeding and survival.
Although yellow fever is not established in countries such as the UK, international travel means infected individuals may return home after becoming infected abroad.
Fortunately, because the mosquito species responsible for sustained transmission are not established in the UK, onward spread is extremely unlikely.
Yellow fever is found almost exclusively in tropical and subtropical regions of Africa and South America.
The virus survives because of a close relationship between mosquitoes, humans and non-human primates living in suitable ecological environments.
Rather than thinking about national borders, it's often more helpful to think about ecosystems.
Yellow fever thrives in areas with:
These environmental conditions allow the virus to continue circulating even when human cases are relatively low.
Patients often ask why diseases like yellow fever remain confined to certain parts of the world.
Several factors protect countries such as the UK.
British weather is generally too cool to support sustained transmission by the mosquitoes responsible for spreading yellow fever.
Although mosquitoes exist in the UK, the species capable of maintaining large outbreaks of yellow fever are not naturally established.
Rapid surveillance, disease reporting and travel health measures reduce the likelihood of imported infections leading to wider transmission.
The yellow fever virus has existed in forest ecosystems long before humans recognised the disease.
In tropical rainforests:
This explains why occupations and activities involving prolonged exposure to forests can increase the risk of infection.
Examples include:
The incubation period is the time between becoming infected and developing symptoms.
For yellow fever, this is usually:
3–6 days
During this period:
Because symptoms don't appear immediately after the mosquito bite, many travellers fail to associate their illness with an insect bite received several days earlier.
The severity of yellow fever varies considerably.
Some people experience only a mild illness.
Others develop rapidly progressive disease requiring emergency medical care.
One of the challenges for both patients and clinicians is that the earliest symptoms resemble many common viral infections.
Most patients first develop symptoms that resemble influenza.
These commonly include:
Many people begin to recover after several days without developing further complications.
If the infection progresses, additional symptoms may appear.
These include:
These symptoms require immediate hospital assessment.
This is one of the most important unanswered questions in yellow fever research.
While scientists understand how the virus infects the body, predicting who will develop severe disease remains difficult.
Several factors appear to influence severity.
Higher levels of virus may increase the likelihood of complications.
Sometimes the body's own inflammatory response contributes to tissue damage.
Very young children and older adults may have a greater risk of severe illness.
Existing health problems affecting immunity may reduce the body's ability to control infection.
People who delay seeking medical attention after symptoms develop may present with more advanced disease.
One of the most distinctive features of yellow fever is that the illness does not always follow a straightforward course. Some people recover after a few days of fever, while others experience a temporary improvement before becoming critically ill.
This pattern can make the disease difficult to recognise, particularly during its early stages.
Although every patient is different, yellow fever is often described as progressing through three clinical phases.
The first stage begins after the incubation period and usually lasts three to four days.
During this phase, the virus is actively multiplying in the body and the immune system begins responding to the infection.
Typical symptoms include:
At this stage, the illness can resemble influenza, dengue fever or other viral infections, making travel history an essential part of the assessment.
After the initial illness, many patients start to feel better.
Their fever settles, appetite improves and energy levels begin to return. This recovery phase usually lasts between 24 and 48 hours.
For most people, this marks the beginning of a full recovery.
However, a smaller group of patients enter a third and far more serious phase of illness.
The toxic phase develops in a minority of patients but accounts for most severe complications associated with yellow fever.
During this stage, widespread inflammation affects multiple organs and disrupts normal blood clotting.
Symptoms may include:
Patients with these symptoms require urgent hospital care, often in a high-dependency or intensive care setting.
There is no single symptom that confirms yellow fever. Diagnosis relies on combining a patient's clinical presentation, travel history and laboratory investigations.
One of the first questions a doctor is likely to ask is:
"Where have you travelled in the past few weeks?"
This information is often the key to deciding whether yellow fever should be considered.
During the consultation, clinicians will ask about:
Even seemingly minor details—such as spending a day hiking in a rainforest—can influence the assessment.
The examination focuses on identifying signs of systemic illness and organ involvement.
Doctors may assess:
These findings help determine how severely the illness is affecting the body.
Laboratory investigations play an important role in confirming the diagnosis and monitoring disease severity.
Abnormal liver function tests and low platelet counts are common findings in severe disease.
Where yellow fever is suspected, specialist laboratories may perform tests such as:
These tests are usually arranged through specialist public health laboratories rather than routine GP surgeries.
Because the early symptoms are non-specific, doctors also consider other illnesses that can present in a similar way.
These include:
This is why recent travel history is such an important part of assessing anyone who develops a fever after returning from overseas.
At present, there is no specific antiviral medication that eliminates the yellow fever virus.
Treatment focuses on supportive care, helping the body function while the immune system fights the infection.
This is one reason why prevention remains so important.
Treatment depends on the severity of illness.
People with uncomplicated yellow fever may require:
Recovery usually occurs over several days.
Patients with severe disease are admitted to hospital for close monitoring.
Treatment may include:
Although these treatments do not kill the virus, they can support the body's recovery and reduce the risk of complications.
Most people recover fully from yellow fever, but severe infection can lead to significant complications.
These may include:
Damage to liver cells may impair blood clotting, detoxification and bilirubin metabolism.
Reduced kidney function can lead to dehydration, electrolyte imbalance and the need for specialist support.
Damage to blood vessels and clotting mechanisms may cause:
Inflammation affecting the heart can occasionally occur in severe cases, contributing to circulatory instability.
Although uncommon, yellow fever may affect the nervous system, leading to:
Most people who experience mild yellow fever recover completely without lasting health problems.
Recovery from severe disease, however, may take considerably longer.
Some patients report:
Follow-up care is often recommended to monitor organ function and ensure recovery is progressing as expected.
People who recover from yellow fever generally develop long-lasting immunity to the virus.
This means reinfection is considered uncommon.
However, relying on natural infection to gain immunity is never advisable given the potentially serious consequences of the disease.
Although yellow fever remains a potentially serious disease, it is also one of the most preventable mosquito-borne infections. Prevention involves reducing exposure to infected mosquitoes and, where appropriate, receiving vaccination before travelling to areas where the virus is endemic.
Unlike many infectious diseases, there is no single measure that eliminates risk entirely. A combination of personal protection, informed travel planning and public health measures provides the greatest level of protection.
Mosquito avoidance remains important, even for vaccinated travellers, as mosquitoes can also transmit other infections such as dengue, Zika and chikungunya.
Practical ways to reduce mosquito bites include:
These simple measures can significantly reduce the likelihood of mosquito bites during travel.
Vaccination remains the most effective way to prevent yellow fever in people travelling to regions where the disease is present.
However, the vaccine is not routinely recommended for everyone. The decision depends on factors such as:
Rather than repeating detailed guidance here, readers who want to understand who should receive the vaccine, when it should be given, possible side effects and International Certificate requirements can read our dedicated guide on Yellow Fever Vaccine.
Preventing yellow fever is not solely the responsibility of individual travellers.
Health authorities around the world also help reduce transmission through:
These coordinated measures have played a significant role in reducing the global burden of yellow fever over recent decades.
Misinformation can lead people to underestimate—or overestimate—the risks associated with yellow fever. Understanding the facts helps travellers make informed decisions.
Fact: Although both diseases are spread by mosquitoes and occur in some of the same regions, they are caused by completely different organisms. Yellow fever is caused by a virus, whereas malaria is caused by a parasite.
Fact: Jaundice is a feature of severe disease. Many people experience mild illness or recover before liver damage develops.
Fact: Mosquito bites are often painless and may go unnoticed. Many travellers never recall the bite that transmitted the infection.
Fact: Under normal circumstances, yellow fever requires an infected mosquito to spread the virus. It is not transmitted through coughing, sneezing, touching or sharing food.
Fact: Some patients experience a brief period of improvement before progressing to a more severe phase of illness. Persistent or worsening symptoms should always be assessed by a healthcare professional.
Yellow fever is a viral disease spread by infected mosquitoes in parts of Africa and South America. It can cause anything from a mild flu-like illness to severe disease affecting the liver, kidneys and other organs.
No. Yellow fever does not usually spread directly from person to person. Infection occurs through the bite of an infected mosquito.
The name comes from jaundice, a yellowing of the skin and eyes caused by liver damage in severe cases.
Symptoms typically develop three to six days after being bitten by an infected mosquito.
Early symptoms commonly include fever, headache, muscle aches, chills, nausea, vomiting and fatigue.
There is no specific antiviral treatment. Medical care focuses on supporting the body's recovery and treating complications if they occur.
Yes. Preventive measures include avoiding mosquito bites and receiving vaccination when recommended for travel to affected areas.
Anyone can develop severe illness, but older adults, young children and people with weakened immune systems may have a higher risk of complications.
Yellow fever is not naturally transmitted within the UK because the mosquitoes responsible for spreading the virus are not established here.
Seek prompt medical assessment if you develop fever or flu-like symptoms after travelling to a region where yellow fever occurs, particularly if symptoms worsen or you notice jaundice, bleeding or confusion.
Same Day Online Booking
No Time Limits Appointments
Online Consultations Available
Latest Blog Posts
How Long Does the Yellow Fever Vaccine Last? Do You Need a Booster?
Yellow Fever Vaccine: Everything You Need to Know Before Travel
The 14 Regulated Food Allergens Explained | UK Food Law Guide
Oral Allergy Syndrome: Why Hay Fever Makes Your Mouth Tingle When You Eat Fruit
What Is MCV in a Blood Test? Understanding High, Low and Normal MCV Results
What Does RDW Mean in a Blood Test? Causes of High and Low RDW Explained
Ready to take the next step?
Before you go
STRUGGLING WITH HAYFEVER THIS SEASON?
Our hayfever treatment is fast, effective often providing relief within 24 hours.
Book Hayfever Treatment →Book a Hayfever Appointment